# US 2015/0174295 A1 · Porous Orthopedic Materials Coated With Demineralized Bone Matrix

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0174295 A1
- Document ID: US20150174295A1
- Status: Published application
- Kind: A1
- Application number: 14/636,487
- Filed: 2015-03-03
- Published: 2015-06-25
- Earliest claimed: 2007-03-21
- Assignees: Biomet Manufacturing, LLC
- Applicants: Biomet Manufacturing, LLC
- Inventors: Jennifer Woodell-May; Karen Troxel
- Web page: https://patentgrep.com/patent/US20150174295A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 27/042: {Iron or iron alloys}
- A61L 27/045: {Cobalt or cobalt alloys}
- A61L 27/047: {Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06}
- A61L 27/06: Titanium or titanium alloys
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 31/005: {Ingredients of undetermined constitution or reaction products thereof}
- A61L 31/10: Macromolecular materials
- A61L 31/124: {of other specific inorganic materials not covered by A61L31/122 or A61L31/123}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 2300/30: Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
- A61L 2300/414: Growth factors
- A61L 2300/606: Coatings
- A61L 2420/02: Methods for coating medical devices
- A61L 2420/06: Coatings containing a mixture of two or more compounds
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A biomaterial including a porous biocompatible structure having interconnected pores, wherein the pores have interior walls and are interconnected by passageways, the interior walls and passageways being coated with an osteoinductive aqueous demineralized bone extract solution, the aqueous demineralized bone extract solution including growth factors, proteins, a demineralized bone matrix and at least one of a weak acid and a guanidine hydrochloride, wherein the demineralized bone matrix is present per 100 g of the solution in an amount of from about 2 g to about 10 g.

## Claims

### Claim 1

A biomaterial comprising:
a porous biocompatible structure comprising interconnected pores, wherein the pores comprise interior walls and are interconnected by passageways;
an aqueous demineralized bone extract coating comprising growth factors, proteins or a combination thereof; and
a demineralized bone gelatin coating comprising a demineralized bone matrix gelatin;
wherein the demineralized bone extract coating and the demineralized bone gelatin coating cover the interior walls and passageways.

### Claim 2 (depends on 1)

The biomaterial of claim 1, wherein the aqueous demineralized bone extract coating and the demineralized bone gelatin coating are combined into a single coating material which covers the interior walls and passageways.

### Claim 3 (depends on 1)

The biomaterial of claim 1, wherein the aqueous demineralized bone extract coating covers the interior walls and passageways and the demineralized bone gelatin coating covers the aqueous demineralized bone extract coating.

### Claim 4 (depends on 1)

The biomaterial of claim 1, wherein the aqueous demineralized bone extract coating and the demineralized bone gelatin coating are dried on the interior walls and passageways.

### Claim 5 (depends on 1)

The biomaterial of claim 1, wherein the aqueous demineralized bone extract coating is an acid soluble demineralized bone coating.

### Claim 6 (depends on 1)

The biomaterial of claim 1, wherein the aqueous demineralized bone extract coating is a guanidine hydrochloride extract.

### Claim 7 (depends on 1)

The biomaterial of claim 1, wherein the porous biocompatible structure comprises a porous metal, hydroxyapatite or xenograft demineralized cancellous bone.

### Claim 8 (depends on 7)

The biomaterial of claim 7, wherein the porous metal is stainless steel, titanium, a titanium alloy, tantalum or a cobalt-chromium alloy.

### Claim 9 (depends on 7)

The biomaterial of claim 7, wherein the hydroxyapatite comprises tricalcium phosphate.

### Claim 10 (depends on 7)

The biomaterial of claim 7, wherein the hydroxyapatite comprises a coralline hydroxyapatite.

### Claim 11 (depends on 1)

The biomaterial of claim 1, wherein the pores have a size of from about 5 microns to about 1000 microns.

### Claim 12 (depends on 1)

The biomaterial of claim 1, wherein the pores have an average diameter of from about 200 microns to about 500 microns.

### Claim 13 (depends on 1)

The biomaterial of claim 1, wherein the biomaterial has a form of granules, blocks, cylinders or pre-formed shapes.

### Claim 14 (depends on 1)

The biomaterial of claim 1, wherein the biomaterial is used as an orthopedic implant.

### Claim 15

A biomaterial comprising:
a porous biocompatible structure comprising interconnected pores, wherein the pores comprise interior walls and are interconnected by passageways, the interior walls and passageways being coated with an osteoinductive aqueous demineralized bone extract solution, the solution comprising growth factors, proteins, a demineralized bone matrix and at least one of a weak acid and a guanidine hydrochloride;
wherein the demineralized bone matrix is present per 100 g of the solution in an amount of from about 2 g to about 10 g.

### Claim 16 (depends on 15)

The biomaterial of claim 15, wherein the demineralized bone extract solution comprises a growth factor.

### Claim 17 (depends on 16)

The biomaterial of claim 16, wherein the growth factor is a bone morphogenic protein, TGF-b, IGF-1, VEGF, PDGF, FGF, EGF or mixtures thereof.

### Claim 18 (depends on 15)

The biomaterial of claim 15, wherein the porous biocompatible structure is metal, wherein the metal is stainless steel, titanium, a titanium alloy, tantalum or a cobalt-chromium alloy.

### Claim 19 (depends on 15)

The biomaterial of claim 15, wherein the porous biocompatible structure is xenograft demineralized cancellous bone.

### Claim 20 (depends on 15)

The biomaterial of claim 15, wherein the porous biocompatible structure is hydroxyapatite, the hydroxyapatite comprising tricalcium phosphate or a coralline hydroxyapatite.

### Claim 21 (depends on 15)

The biomaterial of claim 15, wherein the pores have an average diameter of from about 200 microns to about 500 microns.

### Claim 22 (depends on 15)

The biomaterial of claim 15, further comprising a demineralized bone gelatin coating.

### Claim 23 (depends on 22)

The biomaterial of claim 22, wherein the demineralized bone gelatin coating and the demineralized bone extract solution are combined into a single coating material which covers the interior walls and passageways.

### Claim 24 (depends on 22)

The biomaterial of claim 22, wherein the aqueous demineralized bone extract solution is an acid soluble demineralized bone coating, wherein the acid soluble demineralized bone coating covers the interior walls and passageways of the pores and the demineralized bone gelatin coating covers the acid soluble demineralized bone coating.

### Claim 25 (depends on 15)

The biomaterial of claim 15, wherein the biomaterial has a form of granules, blocks, cylinders or pre-formed shapes.

### Claim 26

An orthopedic implant comprising:
a porous biocompatible structure comprising interconnected pores, wherein the pores comprise interior walls and are interconnected by passageways and wherein the pores have an average diameter of from about 200 microns to about 500 microns; and
an aqueous demineralized bone extract coating comprising growth factors, proteins or a combination thereof, wherein the demineralized bone extract coating covers the interior walls and passageways, wherein the bone extract coating is dried on the interior walls and passageways.

### Claim 27 (depends on 26)

The orthopedic implant of claim 26, wherein the porous biocompatible structure is coralline hydroxyapatite.

### Claim 28 (depends on 26)

The orthopedic implant of claim 26, wherein the demineralized bone extract is an acid soluble extract.

### Claim 29 (depends on 26)

The orthopedic implant of claim 26, wherein the demineralized bone extract is a guanidine hydrochloride extract.

### Claim 30 (depends on 26)

The biomaterial of claim 26, further comprising a demineralized bone gelatin coating, wherein the demineralized bone gelatin coating and the demineralized bone extract are combined into a single coating material which covers the interior walls and passageways.

### Claim 31 (depends on 26)

The biomaterial of claim 26, further comprising a demineralized bone gelatin coating, wherein the demineralized bone extract coating covers the interior walls and passageways and the demineralized bone gelatin coating covers the demineralized bone extract coating.

### Claim 32

A method of preparing a biomaterial comprising:
a. mixing demineralized bone with an aqueous solution, the aqueous solution comprising a weak acid or guanidine hydrochloride, and wherein the mixing proceeds with constant agitation at a temperature of no greater than 50° C. for a time period of from about 8 hours to about 96 hours to prepare a demineralized bone extract;
b. separating the demineralized bone extract from any remaining solids;
c. diluting, removing or neutralizing the weak acid or guanidine hydrochloride in the demineralized bone extract;
d. coating a porous biocompatible structure with the demineralized bone extract, wherein the porous biocompatible structure has a porosity comprising interconnected pores, the pores comprising interior walls and interconnected by passageways, and wherein the demineralized bone extract infiltrates the pores and coats the interior walls and passageways; and
e. drying the applied demineralized bone extract onto the porous biocompatible structure.

### Claim 33 (depends on 32)

The method of claim 32, wherein the aqueous solution comprises a weak acid, wherein the weak acid is citric acid, lactic acid, malic acid, acetic acid or a combination thereof.

### Claim 34 (depends on 32)

The method of claim 32, wherein the aqueous solution comprises a weak acid, the weak acid having a concentration of from about 2 M to about 3 M.

### Claim 35 (depends on 32)

The method of claim 32, wherein the weak acid or the guanidine hydrochloride is neutralized by adjusting the pH to from about 6.5 to about 7.5 by titrating with a counterion.

### Claim 36 (depends on 32)

The method of claim 32, wherein the aqueous solution comprises guanidine hydrochloride, the guanidine hydrochloride having a concentration of from about 3 M to about 6 M.

### Claim 37 (depends on 32)

The method of claim 32, wherein the weak acid or the guanidine hydrochloride is removed from the demineralized bone extract by dialysis, ultrafiltration, hollow fiber filtration or crossflow filtration.

### Claim 38 (depends on 32)

The method of claim 32, wherein an amount of demineralized bone mixed with the aqueous solution is from about 4 grams to about 7 grams of demineralized bone per about 100 grams of aqueous solution.

### Claim 39 (depends on 32)

The method of claim 32, wherein the mixing proceeds for a time period of from about 24 hrs to about 96 hrs.

### Claim 40 (depends on 32)

The method of claim 32, wherein the mixing proceeds for a time period of from about 24 hrs to about 96 hrs.

### Claim 41 (depends on 32)

The method of claim 32, wherein the demineralized bone extract infiltrates the pores under vacuum.

### Claim 42 (depends on 32)

The method of claim 32, wherein the demineralized bone extract infiltrates the pores by capillary action.

### Claim 43 (depends on 32)

The method of claim 32, wherein the porous biocompatible material comprises a metal, hydroxyapatite or xenograft demineralized cancellous bone.

### Claim 44 (depends on 43)

The method of claim 43, wherein the metal is stainless steel, titanium, a titanium alloy, tantalum or a cobalt-chromium alloy.

### Claim 45 (depends on 43)

The method of claim 43, wherein the hydroxyapatite is a coralline hydroxyapatite.

### Claim 46 (depends on 32)

The method of claim 32, wherein the pores have an average diameter of from about 200 microns to about 500 microns.

### Claim 47 (depends on 32)

The method of claim 32, wherein the demineralized bone extract is mixed with a collagen gel before coating the porous biocompatible material and wherein the porous biocompatible material is coated with the combined demineralized bone extract and collagen gel.

### Claim 48 (depends on 32)

The method of claim 32, further comprising:
f. mixing the solids separated out in step b with an aqueous saline solution to form a suspension;
g. heating the suspension to a temperature of from about 85° C. to about 130° C. at a pressure of at least 15 psig, dissolving the demineralized bone to produce a demineralized bone gelatin; and
h. mixing the demineralized bone gelatin with the demineralized bone extract before coating the biocompatible structure.

### Claim 49 (depends on 32)

The method of claim 32, further comprising the steps of:
f. mixing the solids separated out in step b with an aqueous saline solution to form a suspension;
g. heating the suspension to a temperature of from about 85° C. to about 130° C. at a pressure of at least 15 psig, dissolving the demineralized bone to produce a demineralized bone gelatin solution;
h. applying the demineralized bone gelatin solution over the dried demineralized bone extract on the biocompatible structure, wherein the demineralized bone gelatin solution infiltrates the pores and coats the interior walls and passageways;
i. allowing the applied demineralized bone gelatin solution to gel; and
j. lyophilizing the biocompatible structure and the applied demineralized bone gelatin solution.
